These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

233 related articles for article (PubMed ID: 26516926)

  • 1. PTTG regulates the metabolic switch of ovarian cancer cells via the c-myc pathway.
    Wang X; Duan W; Li X; Liu J; Li D; Ye L; Qian L; Yang A; Xu Q; Liu H; Fu Q; Wu E; Ma Q; Shen X
    Oncotarget; 2015 Dec; 6(38):40959-69. PubMed ID: 26516926
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The c-Myc-LDHA axis positively regulates aerobic glycolysis and promotes tumor progression in pancreatic cancer.
    He TL; Zhang YJ; Jiang H; Li XH; Zhu H; Zheng KL
    Med Oncol; 2015 Jul; 32(7):187. PubMed ID: 26021472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PTTG overexpression promotes lymph node metastasis in human esophageal squamous cell carcinoma.
    Yan S; Zhou C; Lou X; Xiao Z; Zhu H; Wang Q; Wang Y; Lu N; He S; Zhan Q; Liu S; Xu N
    Cancer Res; 2009 Apr; 69(8):3283-90. PubMed ID: 19351864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor suppressor NDRG2 inhibits glycolysis and glutaminolysis in colorectal cancer cells by repressing c-Myc expression.
    Xu X; Li J; Sun X; Guo Y; Chu D; Wei L; Li X; Yang G; Liu X; Yao L; Zhang J; Shen L
    Oncotarget; 2015 Sep; 6(28):26161-76. PubMed ID: 26317652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. JQ1 suppresses tumor growth through downregulating LDHA in ovarian cancer.
    Qiu H; Jackson AL; Kilgore JE; Zhong Y; Chan LL; Gehrig PA; Zhou C; Bae-Jump VL
    Oncotarget; 2015 Mar; 6(9):6915-30. PubMed ID: 25762632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic alterations caused by HNF1β expression in ovarian clear cell carcinoma contribute to cell survival.
    Amano Y; Mandai M; Yamaguchi K; Matsumura N; Kharma B; Baba T; Abiko K; Hamanishi J; Yoshioka Y; Konishi I
    Oncotarget; 2015 Sep; 6(28):26002-17. PubMed ID: 26318292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of angiogenesis and invasion by human Pituitary tumor transforming gene (PTTG) through increased expression and secretion of matrix metalloproteinase-2 (MMP-2).
    Malik MT; Kakar SS
    Mol Cancer; 2006 Nov; 5():61. PubMed ID: 17096843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitor of differentiation 1 transcription factor promotes metabolic reprogramming in hepatocellular carcinoma cells.
    Sharma BK; Kolhe R; Black SM; Keller JR; Mivechi NF; Satyanarayana A
    FASEB J; 2016 Jan; 30(1):262-75. PubMed ID: 26330493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long non-coding RNA CTSLP8 mediates ovarian cancer progression and chemotherapy resistance by modulating cellular glycolysis and regulating c-Myc expression through PKM2.
    Li X; Zhang Y; Wang X; Lin F; Cheng X; Wang Z; Wang X
    Cell Biol Toxicol; 2022 Dec; 38(6):1027-1045. PubMed ID: 34510316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene regulatory networking reveals the molecular cue to lysophosphatidic acid-induced metabolic adaptations in ovarian cancer cells.
    Ray U; Roy Chowdhury S; Vasudevan M; Bankar K; Roychoudhury S; Roy SS
    Mol Oncol; 2017 May; 11(5):491-516. PubMed ID: 28236660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene signatures and prognostic analyses of the Tob/BTG pituitary tumor-transforming gene (PTTG) family in clinical breast cancer patients.
    Wu CC; Ekanem TI; Phan NN; Loan DTT; Hou SY; Lee KH; Wang CY
    Int J Med Sci; 2020; 17(18):3112-3124. PubMed ID: 33173433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PTTG/securin activates expression of p53 and modulates its function.
    Hamid T; Kakar SS
    Mol Cancer; 2004 Jul; 3():18. PubMed ID: 15242522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific inhibition of AKT2 by RNA interference results in reduction of ovarian cancer cell proliferation: increased expression of AKT in advanced ovarian cancer.
    Noske A; Kaszubiak A; Weichert W; Sers C; Niesporek S; Koch I; Schaefer B; Sehouli J; Dietel M; Lage H; Denkert C
    Cancer Lett; 2007 Feb; 246(1-2):190-200. PubMed ID: 16584837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modification of the Tumor Microenvironment in KRAS or c-MYC-Induced Ovarian Cancer-Associated Peritonitis.
    Yoshida M; Taguchi A; Kawana K; Adachi K; Kawata A; Ogishima J; Nakamura H; Fujimoto A; Sato M; Inoue T; Nishida H; Furuya H; Tomio K; Arimoto T; Koga K; Wada-Hiraike O; Oda K; Nagamatsu T; Kiyono T; Osuga Y; Fujii T
    PLoS One; 2016; 11(8):e0160330. PubMed ID: 27483433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HSulf-1 deficiency dictates a metabolic reprograming of glycolysis and TCA cycle in ovarian cancer.
    Mondal S; Roy D; Camacho-Pereira J; Khurana A; Chini E; Yang L; Baddour J; Stilles K; Padmabandu S; Leung S; Kalloger S; Gilks B; Lowe V; Dierks T; Hammond E; Dredge K; Nagrath D; Shridhar V
    Oncotarget; 2015 Oct; 6(32):33705-19. PubMed ID: 26378042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NFATC1 promotes cell growth and tumorigenesis in ovarian cancer up-regulating c-Myc through ERK1/2/p38 MAPK signal pathway.
    Xu W; Gu J; Ren Q; Shi Y; Xia Q; Wang J; Wang S; Wang Y; Wang J
    Tumour Biol; 2016 Apr; 37(4):4493-500. PubMed ID: 26501422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isoflurane promotes glucose metabolism through up-regulation of
    Guo NL; Zhang JX; Wu JP; Xu YH
    Biosci Rep; 2017 Dec; 37(6):. PubMed ID: 28951521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression and functional analysis of pituitary tumor transforming gene-1 [corrected] in uterine leiomyomas.
    Tsai SJ; Lin SJ; Cheng YM; Chen HM; Wing LY
    J Clin Endocrinol Metab; 2005 Jun; 90(6):3715-23. PubMed ID: 15769981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transient depletion of p53 followed by transduction of c-Myc and K-Ras converts ovarian stem-like cells into tumor-initiating cells.
    Motohara T; Masuko S; Ishimoto T; Yae T; Onishi N; Muraguchi T; Hirao A; Matsuzaki Y; Tashiro H; Katabuchi H; Saya H; Nagano O
    Carcinogenesis; 2011 Nov; 32(11):1597-606. PubMed ID: 21828057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PTTG and PBF Functionally Interact with p53 and Predict Overall Survival in Head and Neck Cancer.
    Read ML; Modasia B; Fletcher A; Thompson RJ; Brookes K; Rae PC; Nieto HR; Poole VL; Roberts S; Campbell MJ; Boelaert K; Turnell AS; Smith VE; Mehanna H; McCabe CJ
    Cancer Res; 2018 Oct; 78(20):5863-5876. PubMed ID: 30154144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.